BUSINESS: International News Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa By Staff Monday, June 5, 2023 12:19 PM Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301. This therapy is currently being tested in individuals with retinitis pigmentosa (RP). The molecule KIO-301 is designed to turn other retinal cells into light sensors and restore the ability of the eye to sense and interpret light signals. Read More